Research Article

Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two

Table 6

Height and body weight of 2-year-old children.

Characteristic (%)Height, cmBW, kg
Average<−2SD>+2SDAverage<−2SD>+2SD
/M (Q25,Q75)

Gender
Female199 (68.2)87.9 ± 3.20.043#3312.00 (11.00, 12.60)0.93713
Male93 (31.8)98.3 ± 3.30.017#1212.50 (11.80, 13.20)0.73702

Starting age
≤3 months
Female82 (28.1)87.0 ± 2.8①0.7510112.00 (11.00, 12.65)②0.77602
Male35 (12.0)89.0 (87.0, 90.0)③0.5141112.50 (12.00, 12.80)④0.18301
>3 months
Female117 (40.1)87.9 ± 3.5①0.025#3211.85 ± 1.12②0.89111
Male58 (19.9)89.8 ± 3.7③0.010#0112.60 (11.80, 13.50)④0.22201

Preterm birth
Female15 (5.1)88.1 ± 3.6⑤0.4590111.92 ± 1.44⑥0.82002
Male10 (3.4)87.9 ± 3.0⑦0.5270012.17 ± 0.86⑧0.20100
Term birth
Female184 (63.0)87.7 ± 3.2⑤0.0553212.00 (11.00, 12.60)⑥0.82111
Male83 (28.4)89.5 ± 3.3⑦0.008#1212.50 (12.00, 13.20)⑧0.51302

Adverse effect
No
Female162 (55.5)87.9 ± 3.2⑨0.013#2211.94 ± 1.12⑩0.59301
Male76 (26.0)89.3 ± 3.2⑪0.032#1012.50 (11.80, 13.20)⑫0.76801
Yes
Female37 (12.7)86.9 ± 3.2⑨0.3681112.00 (10.75, 12.00)⑩0.46212
Male17 (5.8)89.6 ± 3.7⑪0.3190212.87 ± 1.61 ⑫0.79401

Wilcoxon signed-rank test: compared with standard reference, #, Mann-Whitney U-test: ① ,,,,,,,, t-test: ⑤ ,,,.